ProfileGDS4718 / 222162_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 74% 96% 75% 70% 51% 73% 71% 89% 69% 80% 80% 54% 62% 61% 87% 81% 75% 61% 88% 79% 73% 78% 90% 81% 63% 86% 62% 82% 32% 40% 76% 79% 63% 67% 79% 31% 87% 70% 98% 84% 38% 84% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.2146774
GSM549102patient 115, normal, homogenized [OPG study]7.1353474
GSM549104patient 119, normal, homogenized [OPG study]10.732296
GSM549108patient 138, normal, homogenized [OPG study]7.233875
GSM549119patient 077, normal, homogenized [OPG study]6.8496170
GSM549133patient 032, cancer, homogenized [OPG study]5.5147151
GSM549139patient 042, cancer, homogenized [OPG study]7.1399973
GSM549099patient 107, normal, homogenized [OPG study]6.9383971
GSM549109patient 139, normal, homogenized [OPG study]8.9784689
GSM549110patient 046, normal, homogenized [OPG study]6.7904369
GSM549114patient 063, normal, homogenized [OPG study]7.9259680
GSM549122patient 082, normal, homogenized [OPG study]7.8669180
GSM549134patient 033, cancer, homogenized [OPG study]5.738954
GSM549136patient 036, cancer, homogenized [OPG study]6.2806762
GSM549140patient 044, cancer, homogenized [OPG study]6.1757261
GSM549111patient 047, normal, homogenized [OPG study]8.8445487
GSM549113patient 057, normal, homogenized [OPG study]8.075981
GSM549132patient 031, cancer, homogenized [OPG study]7.381575
GSM549137patient 038, cancer, homogenized [OPG study]6.228661
GSM549142patient 047, cancer, homogenized [OPG study]8.4517288
GSM549100patient 110, normal, homogenized [OPG study]7.6190279
GSM549107patient 135, normal, homogenized [OPG study]7.1703773
GSM549115patient 068, normal, homogenized [OPG study]7.7069578
GSM549116patient 072, normal, homogenized [OPG study]9.2101290
GSM549120patient 078, normal, homogenized [OPG study]7.9941981
GSM549131patient 030, cancer, homogenized [OPG study]6.292963
GSM549118patient 074, normal, homogenized [OPG study]8.6987486
GSM549129patient 027, cancer, homogenized [OPG study]6.2930362
GSM549123patient 088, normal, homogenized [OPG study]8.1358282
GSM549124patient 006, cancer, homogenized [OPG study]4.6787532
GSM549126patient 015, cancer, homogenized [OPG study]4.9878140
GSM549128patient 025, cancer, homogenized [OPG study]7.5177476
GSM549103patient 117, normal, homogenized [OPG study]7.5776779
GSM549117patient 073, normal, homogenized [OPG study]6.2765463
GSM549138patient 041, cancer, homogenized [OPG study]6.676867
GSM549141patient 045, cancer, homogenized [OPG study]7.9187179
GSM549130patient 028, cancer, homogenized [OPG study]4.583631
GSM549101patient 111, normal, homogenized [OPG study]8.735587
GSM549105patient 128, normal, homogenized [OPG study]6.8837270
GSM549106patient 134, normal, homogenized [OPG study]11.484298
GSM549112patient 048, normal, homogenized [OPG study]8.3860284
GSM549125patient 011, cancer, homogenized [OPG study]4.8922538
GSM549127patient 024, cancer, homogenized [OPG study]8.3134784
GSM549135patient 035, cancer, homogenized [OPG study]5.7697955